You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
24 December 2020
Australia is set to consider applications to add several active ingredients to Appendix H of the Poisons Standard, allowing medicines containing the substances to be advertised directly to consumers.
16 December 2020
Australia’s Therapeutic Goods Administration (TGA) has now given the final go-ahead for certain low-dose cannabidiol (CBD) medicines to be sold without a prescription. However, the TGA has made a number of changes to its interim decision released in September 2020.
28 September 2020
Australia’s Therapeutic Goods Administration (TGA) has declared that certain sports supplements are therapeutic goods rather than foods.
11 September 2020
Australia has once again rejected an application to switch the erectile-dysfunction drug sildenafil from prescription to non-prescription status but is set to make another triptan available without a prescription.
11 September 2020
Australia’s Therapeutic Goods Administration (TGA) is set to allow low-dose cannabidiol (CBD) medicines to be sold without a prescription.
28 April 2020
In response to the COVID-19 pandemic, the European Council has adopted the European Commission’s proposal to postpone by one year the date of application of the new Medical Devices Regulation, regulatory agencies around the world have stepped up global collaboration, and the US has taken action on h...
20 March 2020
Australia’s Therapeutic Goods Administration (TGA) has announced sales restrictions on prescription and non-prescription medicines following surges in demand during the COVID-19 pandemic.
20 March 2020
The World Health Organization (WHO) has responded to reports that taking ibuprofen could worsen symptoms of the COVID-19 coronavirus.
24 October 2019
The US Food and Drug Administration (FDA) has updated its approach to homeopathic products, Australia’s Therapeutic Goods Administration (TGA) is consulting on a proposal affecting supports supplements, and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has announced a promotion...
27 September 2019
Regulatory agencies around the world are taking action on medicines containing ranitidine after tests showed some contain "low levels" of a probable human carcinogen called N-nitrosodimethylamine (NDMA).